Anhui Sunhere Pharmaceutical Excipients Co.,Ltd. (SHE:300452)
China
· Delayed Price · Currency is CNY 15.54
-0.16 (-1.02%)
Mar 11, 2026, 11:54 AM CST
SHE:300452 Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Operating Revenue | 924.08 | 871.93 | 827.17 | 694.08 | 607.27 | 520.93 | Upgrade
|
| Other Revenue | 10.64 | 10.64 | 12.09 | 10.44 | 9.43 | 10.26 | Upgrade
|
| Revenue | 934.72 | 882.57 | 839.26 | 704.53 | 616.71 | 531.2 | Upgrade
|
| Revenue Growth (YoY) | 10.85% | 5.16% | 19.12% | 14.24% | 16.10% | 14.46% | Upgrade
|
| Cost of Revenue | 646.9 | 609.34 | 573.93 | 495.28 | 438.93 | 366.76 | Upgrade
|
| Gross Profit | 287.82 | 273.23 | 265.33 | 209.24 | 177.78 | 164.44 | Upgrade
|
| Selling, General & Admin | 65.42 | 63.54 | 60 | 51.13 | 52.05 | 43.64 | Upgrade
|
| Research & Development | 44.07 | 40.95 | 41.95 | 34.43 | 26.8 | 18.12 | Upgrade
|
| Other Operating Expenses | 1.96 | -1.69 | 2 | 2.72 | 5.85 | 5.34 | Upgrade
|
| Operating Expenses | 111.4 | 102.8 | 103.99 | 88.23 | 84.7 | 66.93 | Upgrade
|
| Operating Income | 176.42 | 170.43 | 161.34 | 121.01 | 93.08 | 97.51 | Upgrade
|
| Interest Expense | -12.47 | -12.73 | -4.3 | -1.21 | -1.2 | -0.73 | Upgrade
|
| Interest & Investment Income | 15.24 | 20.18 | 11.84 | 9.05 | 6.93 | 4.04 | Upgrade
|
| Currency Exchange Gain (Loss) | 1.88 | 1.88 | 0.37 | 2.56 | -0.28 | -1 | Upgrade
|
| Other Non Operating Income (Expenses) | -1.04 | -0.42 | -0.41 | -0.38 | -0.39 | -0.17 | Upgrade
|
| EBT Excluding Unusual Items | 180.04 | 179.34 | 168.84 | 131.02 | 98.14 | 99.65 | Upgrade
|
| Impairment of Goodwill | -39.13 | -39.13 | - | - | -6.13 | - | Upgrade
|
| Gain (Loss) on Sale of Investments | 4.62 | -3.13 | 8.51 | -2.62 | 1.74 | 0.73 | Upgrade
|
| Gain (Loss) on Sale of Assets | -0.17 | 0.11 | -0.01 | -0.27 | -2.96 | -1.86 | Upgrade
|
| Asset Writedown | -0 | -0 | -1.02 | -0.01 | - | - | Upgrade
|
| Other Unusual Items | 7.51 | 5.17 | 9.5 | 8.29 | 5.89 | 8.65 | Upgrade
|
| Pretax Income | 152.86 | 142.36 | 185.82 | 136.4 | 96.68 | 107.17 | Upgrade
|
| Income Tax Expense | 23.23 | 21.83 | 21.2 | 5.47 | 11.14 | 13.65 | Upgrade
|
| Earnings From Continuing Operations | 129.62 | 120.52 | 164.62 | 130.93 | 85.54 | 93.52 | Upgrade
|
| Minority Interest in Earnings | -0.06 | -1.1 | -3.09 | -0.23 | 3.72 | 0.42 | Upgrade
|
| Net Income | 129.56 | 119.42 | 161.54 | 130.71 | 89.25 | 93.94 | Upgrade
|
| Net Income to Common | 129.56 | 119.42 | 161.54 | 130.71 | 89.25 | 93.94 | Upgrade
|
| Net Income Growth | -19.24% | -26.07% | 23.58% | 46.45% | -4.99% | 11.34% | Upgrade
|
| Shares Outstanding (Basic) | 232 | 234 | 234 | 233 | 235 | 230 | Upgrade
|
| Shares Outstanding (Diluted) | 238 | 234 | 241 | 233 | 235 | 230 | Upgrade
|
| Shares Change (YoY) | -1.85% | -2.88% | 3.29% | -0.63% | 1.93% | -1.27% | Upgrade
|
| EPS (Basic) | 0.56 | 0.51 | 0.69 | 0.56 | 0.38 | 0.41 | Upgrade
|
| EPS (Diluted) | 0.54 | 0.51 | 0.67 | 0.56 | 0.38 | 0.41 | Upgrade
|
| EPS Growth | -17.71% | -23.88% | 19.64% | 47.37% | -6.79% | 12.78% | Upgrade
|
| Free Cash Flow | 157.92 | 90.39 | 77.38 | 65.5 | 72.35 | 64.19 | Upgrade
|
| Free Cash Flow Per Share | 0.66 | 0.39 | 0.32 | 0.28 | 0.31 | 0.28 | Upgrade
|
| Dividend Per Share | 0.300 | 0.300 | 0.250 | 0.250 | 0.231 | 0.192 | Upgrade
|
| Dividend Growth | 20.00% | 20.00% | - | 8.32% | 20.02% | 30.02% | Upgrade
|
| Gross Margin | 30.79% | 30.96% | 31.61% | 29.70% | 28.83% | 30.96% | Upgrade
|
| Operating Margin | 18.87% | 19.31% | 19.22% | 17.18% | 15.09% | 18.36% | Upgrade
|
| Profit Margin | 13.86% | 13.53% | 19.25% | 18.55% | 14.47% | 17.69% | Upgrade
|
| Free Cash Flow Margin | 16.89% | 10.24% | 9.22% | 9.30% | 11.73% | 12.08% | Upgrade
|
| EBITDA | 236.04 | 221.12 | 200.12 | 157.07 | 127.77 | 129.26 | Upgrade
|
| EBITDA Margin | 25.25% | 25.05% | 23.84% | 22.30% | 20.72% | 24.33% | Upgrade
|
| D&A For EBITDA | 59.62 | 50.69 | 38.78 | 36.06 | 34.68 | 31.76 | Upgrade
|
| EBIT | 176.42 | 170.43 | 161.34 | 121.01 | 93.08 | 97.51 | Upgrade
|
| EBIT Margin | 18.87% | 19.31% | 19.22% | 17.18% | 15.09% | 18.36% | Upgrade
|
| Effective Tax Rate | 15.20% | 15.33% | 11.41% | 4.01% | 11.53% | 12.74% | Upgrade
|
| Revenue as Reported | 934.72 | 882.57 | 839.26 | 704.53 | 616.71 | 531.2 | Upgrade
|
| Advertising Expenses | - | 0.97 | 0.86 | 0.64 | 0.44 | 0.55 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.